SCHEMBL845520

SCHEMBL845520

CC(C)(C)OC(=O)Nc1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3NC(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
NPC1 O15118 1/20 0.52
MAPK1 P28482 2/20 0.46
LMNA P02545 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
GAA P10253 1/20 0.44
ALDH1A1 P00352 3/20 0.44
HTT P42858 1/20 0.44
KCNH2 Q12809 1/20 0.43
KDM4E B2RXH2 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
PABPC1 P11940 1/20 0.42
EP300 Q09472 1/20 0.42
CREBBP Q92793 1/20 0.42
CMA1 P23946 1/20 0.42
JAK2 O60674 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13272271 0.95 MEN1 (0.49) MEN1KMT2ANPC1MAPK1LMNA
SCHEMBL10119639 0.92 MEN1 (0.46) MEN1KMT2ANPC1MAPK1LMNA
SCHEMBL845350 0.85 MAPK1 (0.49) MAPK1LMNACYP2C9CYP2C19GAA
SCHEMBL845008 0.82 ALDH1A1 (0.54) MEN1KMT2AMAPK1LMNANPSR1
SCHEMBL844996 0.81 CYP2C9 (0.50) MEN1KMT2ANPC1MAPK1LMNA
SCHEMBL10299164 0.81 NPC1 (0.76) MEN1KMT2ANPC1MAPK1LMNA
SCHEMBL10281278 0.81 NPC1 (0.76) MEN1KMT2ANPC1MAPK1LMNA
SCHEMBL845227 0.81 NPC1 (0.76) MEN1KMT2ANPC1MAPK1LMNA
SCHEMBL845284 0.81 MAPK1 (0.58) MEN1KMT2AMAPK1LMNANPSR1
SCHEMBL845332 0.80 NPC1 (0.52) MEN1KMT2ANPC1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed